❶Thrombophlebitis Diclofenac|Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins|Thrombophlebitis Diclofenac Should Topical NSAIDs Have Strict Heart Risk Warnings?|What is Phlebitis? Treatment & Symptoms for Thrombophlebitis Thrombophlebitis Diclofenac|Topical Diclofenac Gel in Patients With Superficial Inflammation of the administered diclofenac gel versus placebo thrombophlebitis, diclofenac.|Diclofenac Sodium|Medical and Biotech [MESH] Definitions]
Information from the National Library of Medicine Choosing to participate in a study is an important Thrombophlebitis Diclofenac decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your Thrombophlebitis Diclofenac may contact the study research staff using the contacts provided below.
For general information, Learn About Clinical Studies. Ages Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria:. We are updating the design of this site. Try the new test version at https: Warning You have reached the maximum number of saved studies The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Listing Thrombophlebitis Diclofenac study does not mean it has been evaluated by the U. Check this out our disclaimer Thrombophlebitis Diclofenac details. Purpose This study will assess the efficacy, safety and tolerability of topically Thrombophlebitis Diclofenac diclofenac gel versus Thrombophlebitis Diclofenac with respect to the symptom score pain, temperature and size of erythema along the superficial vein.
Diclofenac gel Phase 4. Drug Information available for: The area under the curve AUC of the symptom score pain, temperature and size of erythema along Thrombophlebitis Diclofenac superficial vein. Eligibility Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.
Patients with Thrombophlebitis Diclofenac of topical treatment for inflammatory, painful superficial thrombophlebitis of the upper limb Spontaneous or iatrogenic superficial thrombophebitis of the upper limb Exclusion Criteria: Hypersensitivity to Thrombophlebitis Diclofenac study drug, to actylsalicyclic acid and other non-steroidal antirheumatic agents and to the ingredients of the gel Paitents who had developed asthma, skin reactions or acute rhinitis to acetylsalicylic acid or other non-steroidal antirheumatic agents in the past Therapy with varicose vein remedies, antithrombotic or antiphlogistic Thrombophlebitis Diclofenac as well as corticosteroids for more than 7 days prior to study start Acute deep vein thrombosis and thrombophlebitis extending into other Thrombophlebitis Diclofenac veins Other protocol-defined exclusion criteria may apply.
Please refer to this study by its ClinicalTrials. Novartis Pharmaceuticals Thrombophlebitis Diclofenac Pharmaceuticals. September 15, First Posted: September 18, Last Update Posted: December article source, Last Verified: December Keywords provided by Novartis: Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs. National Library of Medicine U. National Institutes of Health U.
Department of Health and Human Verletzung Blutströmungsgeschwindigkeit. Superficial Thrombophlebitis of the Upper Limb.